NCT01533168View on ClinicalTrials.gov

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2016

Conditions
Leukemia
Interventions
GENETIC

cytogenetic analysis

GENETIC

nucleic acid sequencing

OTHER

diagnostic laboratory biomarker analysis

OTHER

laboratory biomarker analysis

OTHER

medical chart review

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT01533168 - Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter